HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.

about

Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.

P2860

Q38378584-0C146CCE-C67E-4978-A2FD-7AB7E4A91463

P2860

HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.

Item

http://www.wikidata.org/entity/Q41328485

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

HPV E6/E7 mRNA versus HPV DNA ...... f a group of Macedonian women.

@en

type

Item

label

HPV E6/E7 mRNA versus HPV DNA ...... f a group of Macedonian women.

@en

prefLabel

HPV E6/E7 mRNA versus HPV DNA ...... f a group of Macedonian women.

@en

P1476

HPV E6/E7 mRNA versus HPV DNA ...... of a group of Macedonian women

@en

P2093

Katerina Popovska-Jankovic

http://www.w3.org/2001/XMLSchema#string

Shaban Memeti

http://www.w3.org/2001/XMLSchema#string

Sotirija Duvlis

http://www.w3.org/2001/XMLSchema#string

Zaneta Popeska

http://www.w3.org/2001/XMLSchema#string

Zorica Sarafinovska Arsova

http://www.w3.org/2001/XMLSchema#string

P2860

Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study

The causal relation between human papillomavirus and cervical cancer.

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer.

HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.

Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.

Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer

P304

1578-1586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.24199

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dijana Plaseska-Karanfilska

P577

2015-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25880030

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.

about

P2860

P2860

HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921